Originally taken over by Eli Lilly , oritavancin was discovered and developed in 2001 by InterMune and in late 2005 by Targanta Therapeutics .
Originally discovered and developed by Eli Lilly , Oritavancin was taken over by InterMune in 2001 and in late 2005 by Targanta Therapeutics .